Treatment of Onchocerciasis: Ivermectin MDA
Module Sequence Completed!
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
Social Sharing!
Share your knowledge:
Suggest Favorite subject or vote for a trending one!
Having trouble? Here are some quick links:
No study tools available yet.
Time on task: 0 mins
No helpful links available yet.
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
Most Gastrointestinal Stromal Tumors (GISTs) are driven by activating mutations in the KIT gene, which encodes a receptor tyrosine kinase (RTK). These mutations lead to ligand-independent dimerization and constitutive activation of the KIT receptor. This, in turn, primarily activates the PI3K/AKT/mTOR and the MAPK (RAS/RAF/MEK/ERK) signaling pathways, promoting cell survival and proliferation. This understanding led to the successful use of the tyrosine kinase inhibitor imatinib as a targeted therapy for GIST.
Break down complex topics into smaller, manageable chunks for easier recall.
Zambia